Manufacturer of Controlled Substances; Notice of Registration; Rhodes Technologies, 43864 [2012-18207]
Download as PDF
<![CDATA[
43864
Federal Register / Vol. 77, No. 144 / Thursday, July 26, 2012 / Notices
calling 303–338–6618 or by email at
biszler@bop.gov.
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
National Institute of Corrections
Manufacturer of Controlled
Substances; Notice of Registration;
Rhodes Technologies
Solicitation for a Cooperative
Agreement—Development of a 21st
Century Corrections Learning
Professional Competency Model
By Notice dated April 17, 2012, and
published in the Federal Register on
April 26, 2012, 77 FR 24986, Rhodes
Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances:
Drug
Schedule
TKELLEY on DSK3SPTVN1PROD with NOTICES
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Rhodes Technologies to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Rhodes Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: July 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–18207 Filed 7–25–12; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
16:42 Jul 25, 2012
Jkt 226001
National Institute of
Corrections, U.S. Department of Justice.
ACTION: Solicitation for a Cooperative
Agreement.
AGENCY:
The National Institute of
Corrections (NIC) is soliciting proposals
from organizations, groups, or
individuals to enter into a cooperative
agreement in a twelve (12) month
project period for the development of a
Corrections Learning Professional
Competency Model. This project will
identify the workplace learning
competencies needed by correctional
learning/training professionals at
different organizational levels. It will
define the competency, identify the
relevant knowledge needed for its
development, describe behaviors that
are reflective of the competency,
identify the skills required to use and
develop the competency and suggest
training strategies appropriate to the
competency. The competency model
will provide the foundation and focus,
in conjunction with the NIC Learning
and Performance White Paper (to be
completed October, 2012), and the
knowledge, skills, behaviors,
responsibilities, and tasks needed for
the future development and delivery of
corrections learning work within the
NIC Academy and the field of
corrections. It will also provide a model
for learning professionals in the field of
corrections.
DATES: Applications must be received
by 4:00 p.m. on Thursday, August 9,
2012.
ADDRESSES: Applicants will be
encouraged to submit their proposals
electronically via https://
www.grants.gov. Applications may also
be sent to: Director, National Institute of
Corrections, 320 First Street NW., Room
5002, Washington, DC 20534.
Applicants submitting proposals nonelectronically should provide three
unbound copies of all documents and
are encouraged to use Federal Express,
UPS, or similar service to ensure
delivery by the due date. Faxed
applications will not be accepted.
FOR FURTHER INFORMATION CONTACT: All
technical or programmatic questions
concerning this announcement should
be directed to Bernie Iszler, Correctional
Program Specialist, National Institute of
Corrections. She can be reached by
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Background: NIC has prioritized
building training capacity in corrections
agencies for decades. Historically the
NIC Academy’s work has included
development of multiple curricula for
corrections trainers and training
administrators based on the field’s
needs, development of new technologies
and the latest workplace learning
research.
As NIC envisions its work with
corrections learning professionals in
this century, we foresee multiple
challenges that need to be addressed
and explored including: A shift in roles
from training director to learning and
performance manager, from trainer to
learning facilitator, a shift from only
classroom content delivery to delivery
in electronic platforms including
synchronous and asynchronous
sessions, a shift from training as an
event to learning as a process including
the creation of learning opportunities on
a continuum from readiness preparation
to on-demand just-in-time availability to
coaching in the workplace. These shifts
call for the development of a new
competency model that places the
learning professional in a position to
enhance the performance of their
agency. (reference: ASTD Competency
Study: Mapping the Future)
Scope of Work: Tasks to be performed
under this cooperative agreement
include: (1) Identify the competencies
needed by correctional learning leaders,
training administrators, trainers,
facilitators, adjunct trainers, subject
matter experts and other levels of
responsibility and job descriptions; (2)
develop a profile for different levels of
correctional learning professionals; (3)
determine, list, and justify which
competencies are most critical to each
level; (4) identify a knowledge base and/
or relevant theories required by the
learning professional to use and develop
the core competencies; (5) identify the
skills required to use and develop the
competencies at each level; (6) identify
behaviors that reflect the core
competencies at each level; and (7)
provide tools with which NIC and
correctional learning professionals in
the field can use to revise and develop
programs with appropriate combination
of theoretical and skill-based content.
Deliverables will include: (1) A brief
narrative review of the project; (2)
Learning professional profiles at
different levels of responsibility and job
descriptions; (3) A narrative describing
existing workplace learning professional
competencies; and (4) The Corrections
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 77, Number 144 (Thursday, July 26, 2012)]
[Notices]
[Page 43864]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18207]
[[Page 43864]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Rhodes Technologies
By Notice dated April 17, 2012, and published in the Federal
Register on April 26, 2012, 77 FR 24986, Rhodes Technologies, 498
Washington Street, Coventry, Rhode Island 02816, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for conversion and sale to dosage form manufacturers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Rhodes Technologies to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Rhodes Technologies to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: July 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-18207 Filed 7-25-12; 8:45 am]
BILLING CODE 4410-09-P
